See more : DHB Capital Corp. (DHBC) Income Statement Analysis – Financial Results
Complete financial analysis of Nano-X Imaging Ltd. (NNOX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nano-X Imaging Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Soaring Eagle Acquisition Corp. (SRNG) Income Statement Analysis – Financial Results
- GE T&D India Limited (GET&D.NS) Income Statement Analysis – Financial Results
- Aries I Acquisition Corporation (RAMMU) Income Statement Analysis – Financial Results
- Paslin Digital Technology Co., Ltd. (600215.SS) Income Statement Analysis – Financial Results
- Catering International & Services Société Anonyme (CTRG.PA) Income Statement Analysis – Financial Results
Nano-X Imaging Ltd. (NNOX)
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.91M | 8.58M | 1.30M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 16.50M | 15.46M | 2.82M | 208.00K | 53.00K | 35.00K |
| Gross Profit | -6.59M | -6.88M | -1.51M | -208.00K | -53.00K | -35.00K |
| Gross Profit Ratio | -66.55% | -80.21% | -115.95% | 0.00% | 0.00% | 0.00% |
| Research & Development | 26.05M | 26.51M | 17.12M | 9.21M | 2.72M | 672.00K |
| General & Administrative | 26.01M | 41.25M | 34.71M | 22.27M | 18.30M | 1.02M |
| Selling & Marketing | 2.38M | 4.38M | 7.03M | 12.45M | 1.56M | 209.00K |
| SG&A | 28.39M | 45.63M | 41.74M | 34.71M | 19.85M | 1.23M |
| Other Expenses | 1.55M | 191.00K | 1.18M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 56.00M | 72.33M | 60.05M | 43.92M | 22.57M | 1.90M |
| Cost & Expenses | 72.49M | 87.79M | 62.86M | 43.92M | 22.57M | 1.90M |
| Interest Income | 1.65M | 789.00K | 288.00K | 108.00K | 8.00K | 0.00 |
| Interest Expense | 0.00 | 60.22M | 288.00K | 0.00 | 0.00 | 5.00K |
| Depreciation & Amortization | 11.81M | 11.51M | 2.29M | 208.00K | 53.00K | 35.00K |
| EBITDA | -47.69M | -75.70M | -59.27M | -43.61M | -22.52M | -1.87M |
| EBITDA Ratio | -481.50% | -433.60% | -4,720.71% | 0.00% | 0.00% | 0.00% |
| Operating Income | -62.59M | -109.71M | -61.56M | -43.92M | -22.57M | -1.90M |
| Operating Income Ratio | -631.89% | -1,278.97% | -4,720.71% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.47M | -14.67M | -288.00K | 108.00K | 8.00K | -5.00K |
| Income Before Tax | -61.12M | -108.92M | -61.85M | -43.82M | -22.56M | -1.91M |
| Income Before Tax Ratio | -617.01% | -1,269.77% | -4,742.79% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -339.00K | -3.68M | -48.00K | -316.00K | -8.00K | 5.00K |
| Net Income | -60.78M | -105.24M | -61.80M | -43.50M | -22.56M | -1.91M |
| Net Income Ratio | -613.59% | -1,226.89% | -4,739.11% | 0.00% | 0.00% | 0.00% |
| EPS | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
| EPS Diluted | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
| Weighted Avg Shares Out | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
| Weighted Avg Shares Out (Dil) | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
Nanox to Report Second Quarter 2023 Financial Results on August 17, 2023
Got $2,500? Buying Shares of This Medical Device Stock Right Now Could Be a Smart Move
Nanox Announces $30 Million Registered Direct Offering
Could Nano-X Imaging Stock Help You Become a Millionaire?
Where Will Nano-X Imaging Be in 3 Years?
Nano-X Imaging: A Very Exciting Opportunity That I Want To Be Part Of
Nano-X Imaging - Some Good, Some Bad
2 Supercharged Growth Stocks That Could Make You Richer
2 Red-Hot Growth Stocks That Are Still Over 300% Away From 2021 Highs
Wall Street Expects Nano-X Imaging Stock to Explode by 120%, and Here's Why It Might
Source: https://incomestatements.info
Category: Stock Reports